insights_auto
Why is GH up 2.50%?
Dive Deeperchevron_right
GH:NASDAQ
Guardant Health Inc
$166.66
arrow_upward
+2.50%(+4.07) 1D
$166.66
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 21, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
$162.29
High
$171.22
Low
$162.00
Mkt. cap
22.37B
Avg. vol.
1.78M
Volume
2.54M
52-wk high
$191.01
52-wk low
$66.59
EPS
-$3.50
Beta
1.58
Shares outstanding
134.20M
No. of employees
2K
Open
$162.29
High
$171.22
Low
$162.00
Mkt. cap
22.37B
Avg. vol.
1.78M
Volume
2.54M
52-wk high
$191.01
52-wk low
$66.59
EPS
-$3.50
Beta
1.58
Shares outstanding
134.20M
No. of employees
2K
News stories
From web sources and news partners
News Corp
·
2 hours ago
7 healthcare stocks that stand out as investors pay up for the sector
Zacks
·
8 hours ago
Natera Partners With TransCode to Advance Colorectal Cancer Trial
Stock Titan
·
1 day ago
Five short talks will explore blood-based cancer tests at ESMO, among 25 studies from Guardant and collaborators.
MarketBeat
·
2 days ago
The AI Trade Just Moved Into Your Bloodstream, and 4 Healthcare Stocks Are Winning
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2.5K
Founded2012
HeadquartersPalo Alto, California, United States
SectorHealth care provider
Websiteguardanthealth.com